NRx Roic from 2010 to 2024

NRXPW Stock  USD 0.07  0.01  10.56%   
NRx Pharmaceuticals ROIC yearly trend continues to be fairly stable with very little volatility. ROIC is likely to outpace its year average in 2024. ROIC is return on Invested Capital, a profitability ratio that measures the return that an investment generates for those who have provided capital, such as debt holders and equity holders. View All Fundamentals
 
ROIC  
First Reported
2010-12-31
Previous Quarter
10.72269344
Current Value
11.26
Quarterly Volatility
4.20490945
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check NRx Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NRx Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.8 K, Interest Expense of 114 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. NRx financial statements analysis is a perfect complement when working with NRx Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of NRx Pharmaceuticals Correlation against competitors.
For more information on how to buy NRx Stock please use our How to Invest in NRx Pharmaceuticals guide.

Latest NRx Pharmaceuticals' Roic Growth Pattern

Below is the plot of the Roic of NRx Pharmaceuticals over the last few years. It is return on Invested Capital, a profitability ratio that measures the return that an investment generates for those who have provided capital, such as debt holders and equity holders. NRx Pharmaceuticals' ROIC historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NRx Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Roic10 Years Trend
Slightly volatile
   Roic   
       Timeline  

NRx Roic Regression Statistics

Arithmetic Mean1.05
Geometric Mean0.06
Coefficient Of Variation399.48
Mean Deviation2.65
Median(0.01)
Standard Deviation4.20
Sample Variance17.68
Range15.4446
R-Value0.44
Mean Square Error15.30
R-Squared0.20
Significance0.1
Slope0.42
Total Sum of Squares247.54

NRx Roic History

2024 11.26
2023 10.72
2022 -2.19
2021 -4.18
2020 0.29
2019 -1.65E-4

About NRx Pharmaceuticals Financial Statements

NRx Pharmaceuticals investors use historical fundamental indicators, such as NRx Pharmaceuticals' Roic, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in NRx Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
ROIC 10.72  11.26 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for NRx Stock Analysis

When running NRx Pharmaceuticals' price analysis, check to measure NRx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRx Pharmaceuticals is operating at the current time. Most of NRx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRx Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.